Snapshot from Jul 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Australia — Therapeutic Goods Administration

Tracked across 3 events · 26 articles · First seen May 05, 2026 · Last active Jun 29, 2026

Sentiment
0
Attention
4
Events
3
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 0
Regulatory
Impact: The Australia — Therapeutic Goods Administration granted approval for 4DMedical Limited's CT:VQ technology, allowing its commercial deployment in Australia. This regulatory body's decision is crucial for market access.
Jun 29, 2026 · 8 articles
4 0
Business
Impact: The Australia — Therapeutic Goods Administration in Australia oversees the Authorized Prescriber Scheme, under which Optimi Health's psilocybin is prescribed and reimbursed, facilitating patient access to psychedelic medicine.
Jun 29, 2026 · 12 articles
2 0
Business
May 05, 2026 · 6 articles
Australia Australia — Therapeutic Goods Administration
Australia Australia — Therapeutic Goods Administration
ERGEN INTELLIGENCE
Track Australia — Therapeutic Goods Administration live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.